Table 3 Baseline characteristics of the abdominal obesity subjects

From: Prevention of metabolic disorders with telmisartan and indapamide in a Chinese population with high-normal blood pressure

 

Placebo group (n=153)

Telmisartan group (n=149)

Indapamide group (n=142)

P-value

Age (years)

64.9±7.3

65.1±6.7

65.6±7.1

0.676

Male sex, n (%)

31 (20.3)

30 (20.1)

29 (20.4)

0.912

WC (cm)

91.3±7.3

90.8±6.5

91.1±6.1

0.656

SBP (mm Hg)

134.6±3.0

134.7±2.4

134.7±2.7

0.745

DBP (mm Hg)

81.9±5.1

82.2±4.9

82.2±4.6

0.817

TG (mmol l−1)

1.6±0.5

1.6±0.9

1.5±0.6

0.698

HDL-C (mmol l−1)

1.4±0.4

1.5±0.5

1.5±0.4

0.482

LDL-C (mmol l−1)

2.9±0.8

2.9±0.8

3.1±1.0

0.389

FPG (mmol l−1)

5.3±0.6

5.4±0.6

5.4±0.6

0.911

  1. Abbreviations: DBP, diastolic blood pressure; FPG, fasting plasma glucose; HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol; SBP, systolic blood pressure; TG, triglycerides; WC, waist circumference.
Back to article page